“Why Patients Visit Their Doctors: Assessing the Most Prevalent Conditions in a Defined American Population.” Mayo Clinic Proceedings, vol. Prevalence and costs of skin cancer treatment in the U.S., 11. 12: Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. Patient related outcome measures, 6, 229. Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis. 10: “Melanoma of the Skin - Cancer Stat Facts.” SEER, National Cancer Institute, 2019, /statfacts/html/melan.html. 9: Merritt Hawkins: 2017 Physician Appointment Wait Time and Medicare and Medicaid Acceptance Rates. 6: “Cancer Facts & Figures 2019.” American Cancer Society, 2019, 7: “Skin Cancer Facts & Statistics.” The Skin Cancer Foundation,, 8: Coups EJ et al, Am J Med. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. ![]() 5: Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. ![]() ![]() "Elastic scattering spectroscopy in assessing skin lesions: an “in vivo” study." Photodiagnosis and photodynamic therapy 9.2 (2012): 132-141. Photochemistry and Photobiology 2: JCE Underwood, Chap. ![]() Optical Spectroscopy as a Method for Skin Cancer Risk Assessment. 1: Rodriguez‐Diaz, Eladio & Manolakos, Danielle & Christman, Holly & Bonning, Michael & Geisse, John & A'Amar, Ousama & Leffell, David & Bigio, Irving.
0 Comments
Leave a Reply. |